Evidence map›Paper›PMID 36471360›Full record

ArticleBreast cancer research : BCR2022

Associations between quantitative measures of TDLU involution and breast tumor molecular subtypes among breast cancer cases in the Black Women's Health Study: a case-case analysis.

Brittny C Davis Lynn, Brittany D Lord, Renata Cora, Ruth M Pfeiffer, Scott Lawrence, Gary Zirpoli, Traci N Bethea, Julie R Palmer, Gretchen L Gierach

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Brittny C Davis LynnDivision of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, USA.
Brittany D LordDivision of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, USA.
Renata Cora, Stamford, CT, USA.
Ruth M PfeifferDivision of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, USA.
Scott LawrenceMolecular and Digital Pathology Laboratory, Leidos Biomedical Research, Inc., 9615 Medical Center Drive, Rockville, MD, USA.
Gary ZirpoliSlone Epidemiology Center, Boston University, 72 East Concord Street L-7, Boston, MA, USA.
Traci N BetheaOffice of Minority Health and Health Disparities Research, Georgetown Lombardi Comprehensive Cancer Center, 1000 New Jersey Ave SE, Washington, DC, USA.
Julie R Palmer *Slone Epidemiology Center, Boston University, 72 East Concord Street L-7, Boston, MA, USA.
Gretchen L Gierach *Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, USA. gierachg@mail.nih.gov.
National Cancer Institute · USBoston University · USLeidos (United States) · USOffice of Minority Health · USStamford Hospital · US

Funding

A Follow-up Study for Causes of Cancer in Black WomenU01CA164974 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Kimberly A. Bertrand, Yvette C Cozier · 2017 to 2026
$24.0M
Gene Polymorphisms in Relation to Cancer in Black WomenR01CA098663 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI PALMER, JULIE R · 2003 to 2012
$5.3M
NCI NIH HHS R01 CA098663NCI NIH HHS U01 CA164974
6 · The paper itself

Abstract

backgroundTerminal duct lobular units (TDLUs) are the structures in the breast that give rise to most breast cancers. Previous work has shown that TDLU involution is inversely associated with TDLU metrics, such as TDLU count/100mm

methodsWe assessed quantitative TDLU metrics (TDLU count/100mm

resultsOlder age and higher BMI were associated with lower TDLU metrics and larger tumor size and lymph node invasion with higher TDLU metrics. The odds of TN compared with luminal A breast cancer increased with increasing tertiles of TDLU metrics, with odds ratios (95% confidence intervals) for tertile 3 versus tertile 1 of 2.18 (0.99, 4.79), 2.77 (1.07, 7.16), and 1.77 (0.79, 3.98) for TDLU count, TDLU span, and acini count/TDLU, respectively.

conclusionAssociations of TDLU metrics with breast cancer subtypes in the BWHS are consistent with previous studies of White and Asian women, demonstrating reduced TDLU involution in TN compared with luminal A breast cancers. Further investigation is needed to understand the factors that influence TDLU involution and the mechanisms that mediate TDLU involution and breast cancer subtype.

Indexed as

Breast NeoplasmsMammary Glands, HumanTriple Negative Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesFemaleHumansReceptors, ProgesteroneRisk FactorsWomen's HealthErb-b2 Receptor Tyrosine KinasesReceptors, ProgesteroneBreast cancer risk factorsLuminal ATDLU involutionTerminal duct lobular unitTriple-negative

Identifiers

PMID36471360
PMCPMC9720909
OpenAlexW4311521153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.